Chromium Picolinate Does Not Improve Key Features of Metabolic Syndrome in Obese Nondiabetic Adults
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The use of chromium-containing dietary supplements is widespread among patients with type 2 diabetes. Chromium's effects in patients at high risk for developing diabetes, especially those with metabolic syndrome, is unknown. The objective of this study was to determine the effects of chromium picolinate (CrPic) on glucose metabolism in patients with metabolic syndrome. METHOD: A double-blind, placebo-controlled, randomized trial was conducted at a U.S. academic medical center. Sixty three patients with National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III)-defined metabolic syndrome were included. The primary end point was a change in the insulin sensitivity index derived from a frequently sampled intravenous glucose tolerance test. Prespecified secondary end points included changes in other measurements of glucose metabolism, oxidative stress, fasting serum lipids, and high sensitivity C-reactive protein. RESULTS: After 16 weeks of CrPic treatment, there was no significant change in insulin sensitivity index between groups (P = 0.14). However, CrPic increased acute insulin response to glucose (P 0.02). CrPic had no significant effect on other measures of glucose metabolism, body weight, serum lipids, or measures of inflammation and oxidative stress. CONCLUSION: CrPic at 1000 microg/day does not improve key features of the metabolic syndrome in obese nondiabetic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874
Effect of Chromium Supplementation on Glucose Metabolism and Lipids
Balk, E. M., Tatsioni, A., Lichtenstein, A. H., Lau, J., & Pittas, A. G. (2007) · Diabetes Care · doi:10.2337/dc06-0996 · Cited by 294
Chromium picolinate for reducing body weight: Meta-analysis of randomized trials
Pittler, M. H., Stevinson, C., & Ernst, E. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802262 · Cited by 131
Cited by
Moghimi Dehkordi, M., Pournuroz Nodeh, Z., Soleimani Dehkordi, K., salmanvandi, H., Rasouli Khorjestan, R., & Ghaffarzadeh, M. (2024) · Results in Engineering · doi:10.1016/j.rineng.2024.102729 · Cited by 296
Sharma, S., Agrawal, R. P., Choudhary, M., Jain, S., Goyal, S., & Agarwal, V. (2011) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2011.03.003 · Cited by 120
Chromium picolinate supplementation for overweight or obese adults
Tian, H., Guo, X., Wang, X., He, Z., Sun, R., Ge, S., & Zhang, Z. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010063.pub2 · Cited by 57
Tsang, C., Taghizadeh, M., Aghabagheri, E., Asemi, Z., & Jafarnejad, S. (2019) · Clinical Obesity · doi:10.1111/cob.12313 · Cited by 36
Metadata
- Authors
- Iqbal, N., Cardillo, S., Volger, S., Bloedon, L. T., Anderson, R. A., Boston, R., & Szapary, P. O.
- Venue
- Metabolic Syndrome and Related Disorders
- Publisher
- SAGE Publications
- Published
- 2009-04
- Volume
- 7
- Issue
- 2
- Pages
- 143-150
- ISSN
- 1540-4196 (ISSN-L)
- 1557-8518
- OpenAlex
- W2017072808
- Cited by
- 82
- References
- 3
- FWCI
- 7.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chromium Picolinate Does Not Improve Key Features of Metabolic Syndrome in Obese Nondiabetic Adults. https://app.cochat.ai/papers/10.1089/met.2008.0048
- The paper
- Iqbal, N., Cardillo, S., Volger, S., Bloedon, L. T., Anderson, R. A., Boston, R., & Szapary, P. O. (2009). Chromium Picolinate Does Not Improve Key Features of Metabolic Syndrome in Obese Nondiabetic Adults. Metabolic Syndrome and Related Disorders. https://doi.org/10.1089/met.2008.0048
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.